
Sign up to save your podcasts
Or


Click here to get to the homepage of the episode.
We're all making decisions to optimize our studies. Optimizing project plans across different studies presents further challenges. But how to increase the overall portfolio of a company given its limitations leads yet another set of challenges. Knowing how decisions are taken at this top level helps to understand the bigger picture and why this sometimes implies sub-optimal decisions on a study or compound level.
Another big learning from these complex interactions are the influencing skills needed to work with senior and diverse teams.
Only a few statisticians in the industry work in these areas and Andreas Sashegyi is of these.
By Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry4.4
99 ratings
Click here to get to the homepage of the episode.
We're all making decisions to optimize our studies. Optimizing project plans across different studies presents further challenges. But how to increase the overall portfolio of a company given its limitations leads yet another set of challenges. Knowing how decisions are taken at this top level helps to understand the bigger picture and why this sometimes implies sub-optimal decisions on a study or compound level.
Another big learning from these complex interactions are the influencing skills needed to work with senior and diverse teams.
Only a few statisticians in the industry work in these areas and Andreas Sashegyi is of these.

78,438 Listeners

32,021 Listeners

30,680 Listeners

43,548 Listeners

9,533 Listeners

497 Listeners

164 Listeners

344 Listeners

8,529 Listeners

6,090 Listeners

29,202 Listeners

18 Listeners

3,007 Listeners

18 Listeners

23 Listeners